Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Titilope A. Ishola"'
Autor:
B. Mark Evers, Titilope A. Ishola, Jingbo Qiao, Junghee Kang, Dai H. Chung, Piotr G. Rychahou
Publikováno v:
Proceedings of the National Academy of Sciences. 105:12891-12896
Neuroblastoma accounts for nearly 15% of all pediatric cancer-related deaths. We have previously shown that gastrin-releasing peptide (GRP) stimulates neuroblastoma growth, and that its cell surface receptor, GRP-R, is overexpressed in advanced-stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627a052d74a03cd281eaa8f9aa1a5f64
https://doi.org/10.1073/pnas.0711861105
https://doi.org/10.1073/pnas.0711861105
Autor:
Dai H. Chung, Joshua M. Mourot, Titilope A. Ishola, Junghee Kang, B. M. Evers, Piotr G. Rychahou
Publikováno v:
Oncogene. 27:3999-4007
Angiogenesis in neuroblastoma (NB) correlates with increased expression of vascular endothelial growth factor (VEGF) and a worse clinical outcome. Other cellular markers, such as Akt activation and MYCN amplification, are also associated with poor pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a480e80f8cf9dca160c0c9daee8b6a
https://doi.org/10.1038/onc.2008.15
https://doi.org/10.1038/onc.2008.15
Autor:
B. Mark Evers, Jingbo Qiao, Titilope A. Ishola, Dai H. Chung, Piotr G. Rychahou, Jung Hee Kang
Publikováno v:
Biochemical and Biophysical Research Communications. 351:192-197
MYCN amplification strongly correlates with unfavorable outcomes in patients with neuroblastoma. The aim of this study was to investigate the role of MYCN in neuroblastoma cell differentiation and apoptosis. We used the technique of RNA interference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a001e6174a7485f6c5010aaf1d9970f6
https://doi.org/10.1016/j.bbrc.2006.10.020
https://doi.org/10.1016/j.bbrc.2006.10.020
Publikováno v:
Current pediatric reviews. 5(2)
Neuroblastoma is the third most common pediatric cancer in the United States and is responsible for 15% of pediatric cancer-related deaths. Despite major advances in multimodal therapy, the clinical outcome for several patients remains poor. Due to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d801870dc136b50d45469661a6d203
https://pubmed.ncbi.nlm.nih.gov/23606822
https://pubmed.ncbi.nlm.nih.gov/23606822
Autor:
Hita Adwanikar, Cara Ramsey, Yu Fu, Jeong Han, Volker Neugebauer, Titilope A. Ishola, Michelle Scerbo
Publikováno v:
Molecular Pain
Molecular Pain, Vol 4, Iss 1, p 26 (2008)
Molecular Pain, Vol 4, Iss 1, p 26 (2008)
The laterocapsular division of the central nucleus of the amygdala (CeLC) has emerged as an important site of pain-related plasticity and pain modulation. Glutamate and neuropeptide receptors in the CeLC contribute to synaptic and behavioral changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be22c6151b451abcb746b12b05b7fd8d
https://pubmed.ncbi.nlm.nih.gov/18631385
https://pubmed.ncbi.nlm.nih.gov/18631385
Autor:
Titilope A. Ishola, Dai H. Chung
Publikováno v:
Surgical oncology. 16(3)
Neuroblastomas continue to remain a clinical challenge, despite advances in multimodal therapy. Currently, studies are aimed at novel targets for neuroblastoma directed toward poor prognostic indicators such as the MYCN oncogene and marked angiogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e368e117f355272eb74f4aaf53d23dd
https://pubmed.ncbi.nlm.nih.gov/17976976
https://pubmed.ncbi.nlm.nih.gov/17976976
Autor:
Piotr G. Rychahou, Joshua M. Mourot, Jung Hee Kang, Dai H. Chung, B. Mark Evers, Titilope A. Ishola, Naira Baregamian
Publikováno v:
Cancer letters. 253(2)
Gastrin-releasing peptide (GRP), the mammalian equivalent of bombesin (BBS), is a trophic factor for highly vascular neuroblastomas; its mechanisms of action in vivo are unknown. We sought to determine the effects of BBS on the growth of neuroblastom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b3694f85e10182249bc593350457d5
https://pubmed.ncbi.nlm.nih.gov/17383815
https://pubmed.ncbi.nlm.nih.gov/17383815
Publikováno v:
Biochimica et biophysica acta. 1770(6)
Gastrin-releasing peptide (GRP), the mammalian equivalent of bombesin (BBS), is an autocrine growth factor for neuroblastoma; its receptor is up-regulated in undifferentiated neuroblastomas. Phosphatidylinositol 3-kinase (PI3K) is a critical cell sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ebb47fac4e78530eaa2ea21a9535ce
https://pubmed.ncbi.nlm.nih.gov/17379415
https://pubmed.ncbi.nlm.nih.gov/17379415